Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1966 2
1967 3
1968 1
1969 2
1970 3
1972 2
1973 8
1974 6
1975 38
1976 26
1977 29
1978 41
1979 42
1980 40
1981 50
1982 53
1983 48
1984 51
1985 52
1986 59
1987 56
1988 63
1989 77
1990 110
1991 106
1992 88
1993 138
1994 128
1995 132
1996 139
1997 171
1998 159
1999 157
2000 155
2001 191
2002 162
2003 141
2004 155
2005 157
2006 188
2007 190
2008 171
2009 181
2010 192
2011 207
2012 232
2013 224
2014 229
2015 235
2016 217
2017 222
2018 217
2019 228
2020 185
2021 202
2022 114
2023 108
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

6,021 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Adult nodular lymphocyte predominant Hodgkin lymphoma"
Page 1
Hodgkin lymphoma.
Connors JM, Cozen W, Steidl C, Carbone A, Hoppe RT, Flechtner HH, Bartlett NL. Connors JM, et al. Nat Rev Dis Primers. 2020 Jul 23;6(1):61. doi: 10.1038/s41572-020-0189-6. Nat Rev Dis Primers. 2020. PMID: 32703953 Review.
Hodgkin lymphoma (HL) is a B cell lymphoma characterized by few malignant cells and numerous immune effector cells in the tumour microenvironment. The incidence of HL is highest in adolescents and young adults, although HL can affect elderly individual …
Hodgkin lymphoma (HL) is a B cell lymphoma characterized by few malignant cells and numerous immune effector cells in t …
Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Fan Z, et al. Am J Surg Pathol. 2003 Oct;27(10):1346-56. doi: 10.1097/00000478-200310000-00007. Am J Surg Pathol. 2003. PMID: 14508396
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has traditionally been recognized as having two morphologic patterns, nodular and diffuse, and the current WHO definition of NLPHL requires at least a partial nodular pattern. …
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has traditionally been recognized as having two m …
AYA Considerations for Aggressive Lymphomas.
Llaurador G, Giulino-Roth L. Llaurador G, et al. Curr Hematol Malig Rep. 2021 Feb;16(1):61-71. doi: 10.1007/s11899-021-00607-7. Epub 2021 Mar 16. Curr Hematol Malig Rep. 2021. PMID: 33728589 Review.
PURPOSE OF REVIEW: Lymphoma is the one of the most common cancer diagnoses among adolescents and young adults (AYAs) aged 15-39. ...We will discuss the current knowledge about disease biology in AYAs, adult and pediatric treatment strategies, novel tar …
PURPOSE OF REVIEW: Lymphoma is the one of the most common cancer diagnoses among adolescents and young adults (AYAs) aged 15-3 …
Hodgkin's lymphoma in adults.
Townsend W, Linch D. Townsend W, et al. Lancet. 2012 Sep 1;380(9844):836-47. doi: 10.1016/S0140-6736(12)60035-X. Epub 2012 Jul 25. Lancet. 2012. PMID: 22835602 Free article. Review.
Management of Hodgkin's lymphoma continues to develop. Outcomes for patients with favourable-risk, early-stage disease are excellent, and serial reductions in intensity of treatment have been made to retain the excellent prognosis while reducing the late effe …
Management of Hodgkin's lymphoma continues to develop. Outcomes for patients with favourable-risk, early-stage disease …
Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.
Carbone A, Spina M, Gloghini A, Tirelli U. Carbone A, et al. Am J Hematol. 2011 Feb;86(2):170-9. doi: 10.1002/ajh.21910. Am J Hematol. 2011. PMID: 21264899 Free article. Review.
Epidemiologic and molecular findings suggest that classical Hodgkin's lymphoma (CHL) is not a single disease but consists of more than one entity and may occur in different clinical settings. ...In nonimmunosuppressed hosts, according to the age, CHL include …
Epidemiologic and molecular findings suggest that classical Hodgkin's lymphoma (CHL) is not a single disease but consis …
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG.
Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, Ng AK, Roberts KB, Gao S, Balogh A, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis SA, Picardi M, Della Pepa R, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani RH, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT. Binkley MS, et al. Blood. 2020 Jun 25;135(26):2365-2374. doi: 10.1182/blood.2019003877. Blood. 2020. PMID: 32211877 Free article.
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon histologic variant, and the optimal treatment of stage I-II NLPHL is undefined. ...The 5-year PFS rates were 91.1% after RT, 90.5% after CMT, 77.8% after CT, 73.5% after o …
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon histologic variant, and the optima …
Somatostatin-receptor imaging in lymphoma.
Goldsmith SJ, Macapinlac HA, O'Brien JP. Goldsmith SJ, et al. Semin Nucl Med. 1995 Jul;25(3):262-71. doi: 10.1016/s0001-2998(95)80015-8. Semin Nucl Med. 1995. PMID: 7570045 Review.
Patients with Hodgkin's or non-Hodgkin's lymphoma are staged for treatment based on the extent of known disease involvement and the histopathologic grading of the disease. ...Louis, MO) to detect lymphomatous tissue for more accurate staging of …
Patients with Hodgkin's or non-Hodgkin's lymphoma are staged for treatment based on the extent of known disease …
Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle East.
Akhtar S, Rauf MS, Khafaga Y, Al-Kofide A, Elhassan TAM, Elshenawy MA, Nadri J, Mushtaq AH, Bakshi N, Shamayel M, Al-Sweedan S, Sarwar S, Maghfoor I. Akhtar S, et al. BMC Cancer. 2021 Apr 1;21(1):351. doi: 10.1186/s12885-021-08074-2. BMC Cancer. 2021. PMID: 33794818 Free PMC article.
BACKGROUND: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon variant of Hodgkin lymphoma. ...Stem cell transplant in refractory / multiple relapses resulted in excellent disease control. There is a need …
BACKGROUND: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon variant of Hodgkin …
Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
Wang S, Medeiros LJ, Xu-Monette ZY, Zhang S, O'Malley DP, Orazi A, Zuo Z, Bueso-Ramos CE, Yin CC, Liu Z, Miranda RN, Young KH. Wang S, et al. Ann Diagn Pathol. 2014 Aug;18(4):203-9. doi: 10.1016/j.anndiagpath.2014.03.007. Epub 2014 Apr 13. Ann Diagn Pathol. 2014. PMID: 24852241
Hodgkin lymphoma (HL) is classified into 2 largely distinct subgroups, namely nodular lymphocyte predominant HL (NLPHL) and classic HL (CHL). ...All 8 patients have no history of immunosuppression and presented with localized or systemic lymphad …
Hodgkin lymphoma (HL) is classified into 2 largely distinct subgroups, namely nodular lymphocyte predominant …
Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease.
Ho RCW, Chan TSY, Au-Yeung R, Tang KHK, Hwang YY, Tse E, Kwong YL. Ho RCW, et al. Ann Hematol. 2022 Jan;101(1):99-108. doi: 10.1007/s00277-021-04675-w. Epub 2021 Nov 12. Ann Hematol. 2022. PMID: 34767055
Levels of IgGkappa and IgG4 correlated. Diffuse large B-cell lymphoma (DLBCL) was found in three patients, with one case showing co-existing lymphoma and IgG4-RD in the same lymph node biopsy. The remaining two cases were marginal zone lymphoma (MZL) developi …
Levels of IgGkappa and IgG4 correlated. Diffuse large B-cell lymphoma (DLBCL) was found in three patients, with one case showing co-e …
6,021 results